Trudeau pharmacare could limit drug access, hurt patients
Canada must cautiously approach any policy change that puts patients, innovation and innovative industries at risk
Read MoreCanada must cautiously approach any policy change that puts patients, innovation and innovative industries at risk
Read MoreRuling delaying the Trans Mountain pipeline once again makes it clear we need legislation to clarify what indigenous consultation means
Read MoreWhen a dollar earned triggers higher taxes and simultaneously reduces benefits, what’s left to spend or save?
Read MoreBoth countries partner with the private sector and expect patients to share the cost of treatment
Read MorePublic coverage in Quebec is not only more generous, but drug approval is more timely than anywhere else in the country
Read More